Myocarditis Risk From COVID-19 Vaccines Up To 3 times Higher From Moderna Than Pfizer: Study

Myocarditis Risk From COVID-19 Vaccines Up To 3 times Higher From Moderna Than Pfizer: Study


Myocarditis cases hit levels two-to-three times higher in people with a second dose of the Moderna COVID-19 vaccine than the Pfizer BioNTech COVID-19 vaccine, researcher shows.

American College of Cardiology released a study last week that showed that males and females between 18 and 39 with the Moderna vaccine had higher rates of pericarditis and myocarditis. However, males ages 18-29 had the highest rates after receiving the second dose of Moderna.

The National Institutes of Health reports patients experience symptoms of chest pain, fever, fatigue, shortness of breath, and a rapid or irregular pulse, heart failure, shock or death.

Trending: Radio Host Who Attacked ‘Anti-Vaxxers’ to Take Hiatus Until 2023 After Heart Attack

Researchers pulled data from approximately 3 million people in British Columbia, Canada, and used participants over the age of 18 who were hospitalized for myocarditis, pericarditis, or myopericarditis within

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Daily Truth Report • DailyTruthReport.com
Thanks for sharing!
Send this to a friend